Test Price
2,800 AED✅ Home Collection Available
TERT Gene Sequencing (NGS) for Pulmonary Fibrosis & Bone Marrow Failure Telomeropathy | 2800 AED | 2026 DHA Guidelines
DHA-Approved Genetic Testتحليل تسلسل جين TERT للكشف عن التليف الرئوي وفشل النخاع العظمي المرتبط بالتيلومير في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Laboratory (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by medical team.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
يوفر هذا الفحص الجيني المتقدم تحليلاً دقيقاً لجين TERT للكشف عن الطفرات المسببة للتليف الرئوي العائلي وفشل النخاع العظمي، معتمداً على تقنيات التسلسل الجيني الفائقة وضمان الجودة وفقاً لمعايير ISO 9001:2015.
Test Overview
The TERT Gene Sequencing Test utilizes Next-Generation Sequencing (NGS) to analyze the entire TERT coding region for pathogenic variants associated with familial pulmonary fibrosis and telomere-related bone marrow failure syndromes. This comprehensive genetic screening empowers early risk assessment, precise diagnosis, and tailored clinical surveillance.
يقوم هذا الفحص بتسلسل جين TERT لتحديد الطفرات الممرضة المرتبطة بالتليف الرئوي العائلي وفشل النخاع العظمي الناجم عن خلل التيلوميرات، مما يوفر تقييماً مبكراً للمخاطر وتشخيصاً دقيقاً.
Method Comparison
| Feature | Our Test (NGS) | Conventional Sanger Sequencing |
|---|---|---|
| Precision | Full gene coverage, all variant types | Limited to targeted exons, may miss large rearrangements |
| Method | Next-Generation Sequencing (Illumina platform) | Capillary electrophoresis |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Our NGS test delivers superior sensitivity and comprehensive variant detection.
Pulmonologist
Clinical intent: Diagnosis of familial pulmonary fibrosis, prognosis assessment, and lung transplant candidacy evaluation.
Hematologist
Clinical intent: Investigation of inherited bone marrow failure, aplastic anemia, and telomere biology disorders.
Clinical Geneticist
Clinical intent: Germline TERT mutation interpretation, familial risk counseling, and cascade testing.
2026 ICD-10-CM Codes: J84.112 (Familial pulmonary fibrosis), D61.9 (Aplastic anemia, unspecified), Z15.89 (Genetic susceptibility to other disease).
LOINC Code: 82182-7 (TERT gene targeted mutation analysis by Sequencing).
Physician Insight & Safety Protocol
“As a physician, I understand the profound impact of genetic results on patients and their families. This TERT gene analysis offers early, actionable insights into conditions that can significantly alter health trajectories, but it must always be interpreted alongside clinical findings and family history. Please remain under your physician’s care and never alter your treatment without medical guidance.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic information is not a substitute for ongoing clinical management.
🚨 Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Acute febrile illness, hemodynamic instability, inability to provide informed consent, absence of pre-test genetic counseling, or known contraindication to venipuncture.
- Emergency Red Flags: If you experience sudden shortness of breath, chest pain, high fever with bleeding or bruising, or any sign of acute respiratory distress, seek immediate medical attention at the nearest emergency department.
Patient FAQ & Clinical Guidance
What conditions does the TERT gene sequencing test detect?
Answer: This test identifies TERT gene mutations linked to pulmonary fibrosis and bone marrow failure syndromes. These include familial idiopathic pulmonary fibrosis, dyskeratosis congenita, and aplastic anemia caused by telomere dysfunction. The result helps doctors assess disease risk and plan surveillance.
يحدد هذا الفحص الطفرات في جين TERT المرتبطة بمتلازمات التليف الرئوي وفشل النخاع العظمي مثل التليف الرئوي العائلي وخلل التنسج الخلقي وفقر الدم اللاتنسجي. النتيجة تساعد الأطباء في تقدير المخاطر ووضع خطط المراقبة.
How long does it take to receive results?
Answer: Results are typically available within 3 to 4 weeks from the date of sample collection. The turnaround time ensures meticulous sequencing, bioinformatics analysis, and expert clinical interpretation. A final report will be shared with your ordering physician.
تظهر النتائج عادةً خلال 3 إلى 4 أسابيع من تاريخ جمع العينة، مما يتيح وقتاً كافياً للتحليل الدقيق والتفسير السريري المتخصص. يُرسل التقرير النهائي إلى الطبيب المعالج.
Do I need any special preparation before the test?
Answer: A pre- genetic counseling session is mandatory to discuss implications and draw a pedigree chart. No fasting is required for blood collection. Please provide a detailed clinical history and any relevant family records to ensure accurate variant interpretation.
جلسة استشارة وراثية قبل الفحص إلزامية لمناقشة الآثار ورسم شجرة العائلة. لا يُشترط الصيام، ويُرجى تقديم التاريخ الطبي الكامل والسجلات العائلية لضمان دقة التفسير.
Facility License: 9834453 | ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139)
Support & WhatsApp: +971 54 548 8731 | Home Collection: 8 AM – 11 PM
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians